The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of avadomide (CC-122) in combination with R-CHOP for newly diagnosed DLBCL.
 
Neha Mehta-Shah
Consulting or Advisory Role - Kyowa Hakko Kirin; Kyowa Hakko Kirin
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Genentech/Roche (Inst); Innate Pharma (Inst); Verastem (Inst)
 
Julio C. Chavez
Consulting or Advisory Role - Bayer; Celgene; Juno Therapeutics; Karyopharm Therapeutics; Kite/Gilead; MorphoSys; Novartis; Pfizer; TeneoBio; Verastem
Speakers' Bureau - AstraZeneca; BeiGene; Genentech; Kite/Gilead
Research Funding - Merck (Inst)
 
Pau Abrisqueta
Honoraria - Abbvie; Janssen; Roche
Consulting or Advisory Role - Celgene; Janssen; Roche
Travel, Accommodations, Expenses - Abbvie; Janssen; Roche
 
Nathalie Johnson
Honoraria - Merck; Roche/Genentech
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck; Roche/Genentech
Research Funding - Abbvie
 
Juan Miguel Bergua Burgues
No Relationships to Disclose
 
Carlos Grande-Garcia
Consulting or Advisory Role - Amgen; Celgene; Janssen; Roche
Speakers' Bureau - Amgen; Celgene; Janssen; Roche
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Roche
 
Douglas Stewart
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Gilead Sciences; Janssen; Merck; Novartis; Seagen
 
Kieron Dunleavy
Honoraria - Abbvie; Amgen; AstraZeneca; Atara Biotherapeutics; Celgene; Karyopharm Therapeutics; Kymera; Seagen
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Atara Biotherapeutics; Celgene; Karyopharm Therapeutics; Kymera; Seagen
 
Guillermo Rodriguez
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; EUSA Pharma; Janssen; Roche; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Janssen; Roche; Takeda
 
Juan-Manuel Sancho
Honoraria - Celgene; Gilead Sciences; Janssen; Novartis; Roche; Sanofi
Consulting or Advisory Role - Celgene; Celltrion; Gilead Sciences; Janssen; Novartis; Roche; Sandoz-Novartis
Speakers' Bureau - Janssen; Novartis; Roche
Research Funding - Gilead Sciences; Teva
Travel, Accommodations, Expenses - Roche
 
James Drew
Employment - Bristol-Myers Squibb
 
Chengqing Wu
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Patrick R. Hagner
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
Richard Delarue
Employment - Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Alejandro Martin
Honoraria - Celgene; Gilead Sciences; Janssen-Cilag; Roche; SERVIER
Consulting or Advisory Role - Celgene; iQONE; Kyowa Hakko Kirin; MorphoSys; Roche
Research Funding - Celgene; Janssen-Cilag; Teva
Expert Testimony - Gilead Sciences
Travel, Accommodations, Expenses - Celgene; Roche; SERVIER